News | February 28, 2022
Mankind Pharma completes acquisition of Panacea Biotec’s domestic business for Rs 1872 cr
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
The entire integration and transition of the brands is expected to be completed by March 2022
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
The company performed particularly well in operational eco-efficiency, environmental and social reporting
He has been associated with the Zydus Group since 2009
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
Singhal brings a powerful blend of operational excellence, investor acumen, and visionary thinking
Net profit doubled to Rs. 10.8 crore, with PAT margin expanding by 560 bps to 14.3%, reflecting strong operational execution
To streamline complex medical writing workflows with GenAI
She will lead efforts to deepen regional market presence, foster innovation, and support scientific advancement across South Asia
Subscribe To Our Newsletter & Stay Updated
